A new understanding of how tumours exploit our nervous system is leading to new ways to treat cancer using familiar drugs ...

focused on advancing chemoimmunotherapy antibody-drug conjugates (ADCs) for oncology and autoimmune diseases. The company’s proprietary platforms—ADoBind, a novel dimeric antibody structure, and ...